Clinical trial
Potential Allergens in Wine: Double-blind Placebo-controlled Trial
NCT00163735 · Bayside Health, Other · Completed
Key facts
| NCT number | NCT00163735 |
|---|---|
| Title | Potential Allergens in Wine: Double-blind Placebo-controlled Trial |
| Official title | Potential Allergens in Wine: Double Blind Placebo-controlled Trial and Basophil Activation Analysis |
| Lead sponsor | Bayside Health, Other |
| Collaborators | Australian Wine Research Institute National Health and Medical Research Council, Australia The Alfred |
| Status | Completed |
| Study type | Interventional |
| Conditions | Food Allergy, Anaphylaxis |
| Intervention type | Drug |
| Interventions | Administration of wine fined with potential food allergens |
| Enrollment | 48 |
| Start date | Aug 1, 2002 |
| Primary completion | May 1, 2006 |
| Completion | May 1, 2006 |
| First posted | Sep 14, 2005 |
| Last update posted | Dec 5, 2013 |
| Countries | Australia |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: